NASDAQ:NRC • US6373722023
This NRC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Overall NRC gets a fundamental rating of 5 out of 10. We evaluated NRC against 101 industry peers in the Health Care Providers & Services industry. NRC scores excellent on profitability, but there are some minor concerns on its financial health. NRC has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.6% | ||
| ROE | 82.92% | ||
| ROIC | 16.19% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.44% | ||
| PM (TTM) | 8.44% | ||
| GM | 61.88% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.36 | ||
| Debt/FCF | 5.02 | ||
| Altman-Z | 3.1 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.55 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.2 | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.73 | ||
| EV/EBITDA | 14.84 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.56% |
16.5
+0.49 (+3.06%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.56% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.2 | ||
| Fwd PE | N/A | ||
| P/S | 2.72 | ||
| P/FCF | 23.73 | ||
| P/OCF | 14.12 | ||
| P/B | 26.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.84 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.6% | ||
| ROE | 82.92% | ||
| ROCE | 22.99% | ||
| ROIC | 16.19% | ||
| ROICexc | 16.9% | ||
| ROICexgc | 56.88% | ||
| OM | 16.44% | ||
| PM (TTM) | 8.44% | ||
| GM | 61.88% | ||
| FCFM | 11.46% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.36 | ||
| Debt/FCF | 5.02 | ||
| Debt/EBITDA | 2.48 | ||
| Cap/Depr | 140.43% | ||
| Cap/Sales | 7.79% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.54% | ||
| Profit Quality | 135.72% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.55 | ||
| Altman-Z | 3.1 |
ChartMill assigns a fundamental rating of 5 / 10 to NRC.
ChartMill assigns a valuation rating of 3 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Overvalued.
NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.
The Price/Earnings (PE) ratio for NATIONAL RESEARCH CORP (NRC) is 13.2 and the Price/Book (PB) ratio is 26.7.
The financial health rating of NATIONAL RESEARCH CORP (NRC) is 4 / 10.